NASDAQ: PRENW - Prenetics Holding Company Limited

Rentabilité sur six mois: 0%
Rendement en dividendes: 0.00%

Calendrier des promotions Prenetics Holding Company Limited

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise Prenetics Holding Company Limited

Prenetics Global Limited, a health sciences company, focuses on advancing consumer and clinical health. The company's consumer initiatives is led by IM8, a new health and wellness brand. Its prevention arm, CircleDNA, uses next-generation sequencing (NGS) technology to offer comprehensive consumer DNA test. It also develops and commercializes Insighta, a multi-cancer early detection technology. In addition, the company offers a range of genomic profiling panels tailored for requirements and clinician needs, including ACTOnco, ACT HRD, ACTFusion, and ACTDrug tests.

plus de détails
Further, the company offers ACTLiquid Pro, a sequencing based liquid biopsy assay for pan-solid tumors; ACTMonitor, which provides real time monitoring of drug resistance, treatment response, and cancer recurrence; and ACT Risk, which manages the cancer risk. It operates in Taiwan, Hong Kong, the United Kingdom, and internationally. The company was founded in 2014 and is based in Quarry Bay, Hong Kong and has a presence in the United States.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

IPO date 2022-05-18
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.prenetics.com
Цена ао 0.0104
Changement de prix par jour: 0% (0.0108)
Changement de prix par semaine: +11.34% (0.0097)
Changement de prix par mois: -22.3% (0.0139)
Changement de prix sur 3 mois: +9.09% (0.0099)
Changement de prix sur six mois: 0% (0.0108)
Changement de prix par an: +47.95% (0.0073)
Evolution des prix depuis le début de l'année: +9.09% (0.0099)
Tous les paramètres

Sous-estimation

Nom Signification Grade
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
Total: 2.5

Efficacité

Nom Signification Grade
ROA, % 0 0
ROE, % 0 0
Total: 0

Dividendes

Nom Signification Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Devoir

Nom Signification Grade
Debt/EBITDA 0 10
Total: 10

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % 135.49 10
Rentabilité Ebitda, % 158.67 10
Rentabilité EPS, % 104.33 10
Total: 10
Plus de détails

Superviseur Titre d'emploi Paiement Année de naissance
Mr. Sheng Wu Yeung Co-Founder, Chairperson & CEO 1979 (46 années)
Dr. Chi Hung Tzang Ph.D. Co-Founder & Chief Scientific Officer 1974 (51 année)
Mr. Hoi Chun Lo Chief Financial Officer 1985 (40 années)
Ms. Samantha Kwok Chief of Staff to Group CEO & Vice President of People & Operations
Dr. Yung Ho Wong DPHIL Chief Technology Officer 1982 (43 année)
Dr. Senthil Sundaram M.D. Chief Clinical Officer 1974 (51 année)
Mr. Joel Neoh Chief Consumer Officer & CEO for CircleDNA 1984 (41 année)
Mr. Walt Ling Chief Executive Officer of ACT Genomics

Adresse: Hong Kong, Quarry Bay, Unit 703-706 K11 Atelier King’s Road - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.prenetics.com